
Helius Medical Technologies becomes Solana Company, signing a non-binding agreement with Solana Foundation for SOL token activities and potential discounted purchases.
Helius Medical Technologies has rebranded to Solana Company after filing an amendment with the Delaware Secretary of State. It will retain its HSDT ticker and has entered into a non-binding letter of intent with the Solana Foundation to explore discounted SOL purchases, leveraging $500 million in recent PIPE financing for its digital asset strategy.